← Back to Clinical Trials
Recruiting Phase 2 NCT07340411

NCT07340411 Effect of Chinese Herbal Medicine Nasal Irrigation on the Postoperative Care of Chronic Rhinosinusitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07340411
Status Recruiting
Phase Phase 2
Sponsor Taichung Veterans General Hospital
Condition Chronic Rhinosinusitis
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2023-07-05
Primary Completion 2026-03-01

Trial Parameters

Condition Chronic Rhinosinusitis
Sponsor Taichung Veterans General Hospital
Study Type INTERVENTIONAL
Phase Phase 2
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2023-07-05
Completion 2026-03-01
Interventions
Chinese herbal medicine PowderSalt Powder

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Investigators tried to evaluate the efficacy and safety of Chinese herbal medicine nasal irrigation as an adjuvant therapy after FESS.

Eligibility Criteria

Inclusion Criteria: * 1\. Patients with chronic rhinosinusitis who failed medical treatment 2.Patients underwent bilateral primary functional endoscopic sinus surgery. Exclusion Criteria: * 1\. Patients with a history of immunodeficiency 2.Patients with a history of sinus surgery 3.Patients who receiving antibiotic treatment within a week before functional endoscopic sinus surgery 4.Patients with a pathological diagnosis of fungal sinusitis 5.Patients with a pathological diagnosis of sinonasal tumor

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology